Valuation : Cutia Therapeutics

Market Cap 529M 618M 78.79M 67.76M 63.73M 58.18M 109M 7.45B 109M 756M 292M 3.82B 296M 289M 12.16B P/E 2026 *
-3.18x
P/E 2027 * 11.2x
Enterprise Value 598M 698M 89.03M 76.56M 72.01M 65.74M 123M 8.42B 123M 854M 330M 4.31B 334M 327M 13.73B EV / Sales 2026 *
0.93x
EV / Sales 2027 * 0.45x
Free-Float
32.66%
Yield 2026 *
-
Yield 2027 * -
1 day-2.58%
1 week-10.99%
Current month-10.99%
1 month-32.81%
3 months-52.51%
6 months-63.83%
Current year-62.56%
1 week 1.6
Extreme 1.6
1.83
1 month 1.6
Extreme 1.6
2.5
Current year 1.6
Extreme 1.6
5.51
1 year 1.6
Extreme 1.6
11.2
3 years 1.6
Extreme 1.6
25
5 years 1.6
Extreme 1.6
32.6
10 years 1.6
Extreme 1.6
32.6
Manager TitleAgeSince
Chief Executive Officer 48 31/08/2019
Director of Finance/CFO 36 09/05/2021
Chief Tech/Sci/R&D Officer 42 09/01/2020
Director TitleAgeSince
Director/Board Member 48 11/05/2020
Chairman 63 22/08/2019
Director/Board Member 36 14/11/2022
Date Insider Type Main position Quantity % Market Cap. Importance
15/10/24 Other

Founder

15,000 0.0049%
03/10/24 Other

Chief Financial Officer

20,000 0.0066%
02/10/24 Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
-2.58%-10.99%-83.81%-91.83% 78.79M
-0.88%-0.64%+58.05%+100.51% 1,024B
-1.15%+3.53%+54.25%+71.99% 663B
-1.44%+0.02%+20.65%+72.22% 453B
-0.95%+0.23%+28.96%+37.78% 349B
-3.18%+1.78%+20.66%+41.55% 295B
+0.30%+0.60%-0.40%+11.25% 253B
-1.55%+1.71%+54.15%+71.87% 236B
+0.02%+2.24%-14.59%-55.80% 206B
-0.15%+3.18%+31.24%+104.21% 187B
Average -1.16%-0.05%+16.92%+36.38% 366.74B
Weighted average by Cap. -1.06%+0.52%+37.24%+64.56%

Financials

2026 *2027 *
Net sales 646M 754M 96.22M 82.75M 77.83M 71.05M 133M 9.1B 133M 923M 357M 4.66B 361M 353M 14.84B 1.18B 1.38B 176M 151M 142M 130M 243M 16.62B 244M 1.69B 652M 8.51B 660M 646M 27.12B
Net income -146M -170M -21.71M -18.67M -17.56M -16.03M -29.98M -2.05B -30.08M -208M -80.49M -1.05B -81.54M -79.75M -3.35B 44.25M 51.68M 6.59M 5.67M 5.33M 4.87M 9.1M 623M 9.13M 63.22M 24.44M 319M 24.76M 24.22M 1.02B
Net Debt 68.7M 80.24M 10.23M 8.8M 8.28M 7.56M 14.13M 968M 14.18M 98.16M 37.94M 496M 38.44M 37.6M 1.58B -
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
268
Date Price Change Volume
07/09/26 HK$1.700 -2.58% 255,000
04/09/26 HK$1.745 -0.29% 4,800
03/09/26 HK$1.750 -2.78% 28,400
02/09/26 HK$1.800 +3.45% 40,800
01/09/26 HK$1.740 -8.90% 306,400
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.455CNY
Average target price
9.801CNY
Spread / Average Target
+573.40%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!